Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1CNS 1

Conditions

Lymphoma 2Neuroblastoma 1Lymphoma, Large B-Cell, Diffuse 1Brain Neoplasms 1

Interventions

Filgrastim 4Magnetic Resonance Spectroscopy 3Dexamethasone 3entrectinib 2Vincristine 2Temozolomide 2Pemetrexed 2Methylphenidate 2Methods 2Drug Therapy 2Cytarabine 2Cyclophosphamide 2Carmustine 2trametinib 1sonidegib 1selinexor 1sargramostim 1ribociclib 1gadobutrol 1gadobenic acid 1entinostat 1cc-486 1carboxyamido-triazole 1alovudine 1alectinib 1Zidovudine 1Watchful Waiting 1WP 744 1Topotecan 1Thiotepa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × CUDC-907 × Lymphoid × Clear all
NCT02909777 2026-02-11

Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma

Dana-Farber Cancer Institute

Phase 1 Completed
26 enrolled
CNSLymphoid

Brain Neoplasms, Lymphoma, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡